PulseAugur
EN
LIVE 10:13:29

CVS sells Omnicare pharmacy unit to GenieRx for $250 million

CVS Health has finalized the sale of its Omnicare long-term care pharmacy business to GenieRx for $250 million, following bankruptcy court approval. This divestiture is part of CVS's ongoing strategy to streamline its operations and focus on more profitable ventures. The acquisition by GenieRx, a partnership between Milrose Capital and Integro Healthcare Services, aims to enhance Omnicare's services and build upon its established reputation in serving skilled nursing and assisted living facilities. AI

RANK_REASON Divestiture of a major business unit by a large healthcare company. [lever_c_demoted from significant: ic=1 ai=0.1]

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

CVS sells Omnicare pharmacy unit to GenieRx for $250 million

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Bruce Japsen, Senior Contributor ·

    CVS Sale Of Omnicare Long-Term Care Pharmacy Continues Portfolio Revamp

    A bankruptcy court has approved the sale of CVS Health’s underperforming Omnicare long-term care pharmacy network to GenieRx in a deal valued at $250 million.